FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,161 | -55.5% | 18,472 | 0.0% | 0.07% | -60.9% |
| Q2 2023 | $87,927 | -16.5% | 18,472 | 0.0% | 0.17% | -11.1% |
| Q1 2023 | $105,290 | -67.6% | 18,472 | -42.7% | 0.19% | -71.5% |
| Q4 2022 | $325,443 | +2.3% | 32,254 | +127.7% | 0.67% | +2.6% |
| Q3 2022 | $318,000 | -14.3% | 14,165 | -4.9% | 0.65% | +60.9% |
| Q2 2022 | $371,000 | -20.9% | 14,889 | +23.1% | 0.40% | +16.1% |
| Q1 2022 | $469,000 | -53.1% | 12,095 | -29.1% | 0.35% | -65.0% |
| Q4 2021 | $999,000 | -15.3% | 17,066 | -14.3% | 0.99% | +12.6% |
| Q3 2021 | $1,180,000 | +372.0% | 19,910 | +623.5% | 0.88% | +472.7% |
| Q4 2020 | $250,000 | – | 2,752 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |